Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.730
-0.010 (-0.57%)
At close: Apr 2, 2026, 4:00 PM EDT
1.738
+0.008 (0.48%)
After-hours: Apr 2, 2026, 5:23 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $259.31 million as of April 2, 2026. Its market cap has increased by 146.73% in one year.
Market Cap
259.31M
Enterprise Value
141.55M
1-Year Change
146.73%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $259.31M, a decrease of -35.85%. That is a compound annual growth rate of -3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 259.30M | 51.11% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 263.87M |
| Minerva Neurosciences | 260.73M |
| Sol-Gel Technologies | 259.23M |
| C4 Therapeutics | 256.63M |
| Abeona Therapeutics | 255.58M |
| Adlai Nortye | 255.35M |
| Orchestra BioMed Holdings | 248.71M |
| Silence Therapeutics | 247.98M |